Pfizer Is Dropping $650 Million Into US Manufacturing Tech, and I Think That’s Worth Paying Attention To
I’ll be straight with you: I’m not a Pfizer fan. I don’t take their drugs, and I’m not sure I ever have. But I do like investment in US manufacturing, and $650 million going into a manufacturing technology center here in the States is hard to ignore.
Why This Caught My Eye
When a company that size puts that kind of money into manufacturing technology on US soil, it tells you something about where things are headed. Big players don’t make moves like that without a reason. And when you pair it with everything else happening in manufacturing right now, including the uptick in manufacturing technology orders we’re seeing across the industry, it starts to paint a picture.
More US manufacturing activity is a good thing. Full stop. I don’t care where you sit politically or what you think of the company writing the check.
What Smaller Manufacturers Should Take From This
When a facility that size gets built out, it doesn’t operate in a vacuum. There are suppliers, contractors, and service businesses that end up supporting it. That kind of downstream activity matters if you’re a smaller manufacturer or a service business that works anywhere near that supply chain.
It’s also just a signal. If Pfizer is betting $650 million on US manufacturing tech, and we’re already seeing expansion in manufacturing technology investment across the board, that’s not a blip. That’s a trend worth positioning yourself for.
Questions about how this affects your setup? Schedule a free IT consultation and we’ll walk through it with you.
Wherever your team is based, ACS provides hands-on managed IT support — see how we help businesses in Central Florida.